Upstream processes in antibody production: evaluation of critical parameters.

The demand for monoclonal antibody for therapeutic and diagnostic applications is rising constantly which puts up a need to bring down the cost of its production. In this context it becomes a prerequisite to improve the efficiency of the existing processes used for monoclonal antibody production. This review describes various upstream processes used for monoclonal antibody production and evaluates critical parameters and efforts which are being made to enhance the efficiency of the process. The upstream technology has tremendously been upgraded from host cells used for manufacturing to bioreactors type and capacity. The host cells used range from microbial, mammalian to plant cells with mammalian cells dominating the scenario. Disposable bioreactors are being promoted for small scale production due to easy adaptation to process validation and flexibility, though they are limited by the scale of production. In this respect Wave bioreactors for suspension culture have been introduced recently. A novel bioreactor for immobilized cells is described which permits an economical and easy alternative to hollow fiber bioreactor at lab scale production. Modification of the cellular machinery to alter their metabolic characteristics has further added to robustness of cells and perks up cell specific productivity. The process parameters including feeding strategies and environmental parameters are being improved and efforts to validate them to get reproducible results are becoming a trend. Online monitoring of the process and product characterization is increasingly gaining importance. In total the advancement of upstream processes have led to the increase in volumetric productivity by 100-fold over last decade and make the monoclonal antibody production more economical and realistic option for therapeutic applications.

[1]  David C James,et al.  Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature? , 2005, Biotechnology and bioengineering.

[2]  Nicole Kessler,et al.  Hybridoma growth in a new generation hollow fibre bioreactor: antibody productivity and consistency , 2004, Cytotechnology.

[3]  M. Wirth,et al.  Improvement of the primary metabolism of cell cultures by introducing a new cytoplasmic pyruvate carboxylase reaction. , 1999, Biotechnology and bioengineering.

[4]  Michael J Gramer,et al.  Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms. , 2002, Biotechnology and bioengineering.

[5]  A J Sinskey,et al.  Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells , 1986, Biotechnology and bioengineering.

[6]  Kazunari Takahashi,et al.  Growth rate suppression of cultured mammalian cells enhances protein productivity , 2004, Cytotechnology.

[7]  John J. S. Cadwell,et al.  New Developments in Hollow-Fiber Cell Culture , 2004 .

[8]  J. D. Yang,et al.  Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. , 2000, Biotechnology and bioengineering.

[9]  W F Anderson,et al.  Improved methods of retroviral vector transduction and production for gene therapy. , 1994, Human gene therapy.

[10]  Gyun Min Lee,et al.  Feasibility study on the use of hyperosmolar medium for improved antibody production of hybridoma cells in a long-term, repeated-fed batch culture , 1995 .

[11]  Amine Kamen,et al.  Improving Glucose and Glutamine Metabolism of Human HEK 293 and Trichoplusiani Insect Cells Engineered To Express a Cytosolic Pyruvate Carboxylase Enzyme , 2003, Biotechnology progress.

[12]  F Franek,et al.  Starvation-induced programmed death of hybridoma cells: Prevention by amino acid mixtures. , 1995, Biotechnology and bioengineering.

[13]  Liangzhi Xie,et al.  Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor , 2004, Cytotechnology.

[14]  M. Al‐Rubeai,et al.  Variable functions of bcl-2 in mediating bioreactor stress- induced apoptosis in hybridoma cells , 1998, Cytotechnology.

[15]  R. Spier,et al.  Genetic engineering of hybridoma glutamine metabolism. , 1995, Enzyme and microbial technology.

[16]  William R. Tolbert,et al.  Large-Scale Cell Culture Technology , 1983 .

[17]  Bo Mattiasson,et al.  Polymeric cryogels as promising materials of biotechnological interest. , 2003, Trends in biotechnology.

[18]  D. Carbonell,et al.  DEVELOPMENT OF STRATEGIES FOR THE REMOVAL OF AMMONIA FROM ANIMAL CELL CULTURES , 1992 .

[19]  James M. Piret,et al.  Acoustic Cell Filter for High Density Perfusion Culture of Hybridoma Cells , 1994, Bio/Technology.

[20]  D. Kompala,et al.  Engineering CHO cells to overexpress a secreted reporter protein upon induction from mouse mammary tumor virus promoter. , 2000, Biotechnology and bioengineering.

[21]  Dirk Lütkemeyer,et al.  Effects of dissolved oxygen levels and the role of extra- and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures , 1998, Cytotechnology.

[22]  W M Miller,et al.  Determination of antibody content in live versus dead hybridoma cells: Analysis of antibody production in osmotically stressed cultures , 1992, Biotechnology and bioengineering.

[23]  Daniel I. C. Wang,et al.  Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. , 2001, Biotechnology and bioengineering.

[24]  C A Heath,et al.  Hybridoma growth and antibody production as a function of cell density and specific growth rate in perfusion culture , 1995, Biotechnology and bioengineering.

[25]  S. Dhir,et al.  Dynamic optimization of hybridoma growth in a fed-batch bioreactor. , 2000, Biotechnology and bioengineering.

[26]  R. Pörtner,et al.  Performance of a membrane-dialysis bioreactor with a radial-flow fixed bed for the cultivation of a hybridoma cell line , 1995, Applied Microbiology and Biotechnology.

[27]  D. Kirwan,et al.  Effects of cell density and glucose and glutamine levels on the respiration rates of hybridoma cells , 1990, Biotechnology and bioengineering.

[28]  Andrew J. Racher,et al.  Use of the Glutamine Synthetase (GS) Expression System for the Rapid Development of Highly Productive Mammalian Cell Processes , 2008 .

[29]  Satinder Ahuja,et al.  Handbook of bioseparations , 2000 .

[30]  L Xie,et al.  Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells. , 1997, Trends in biotechnology.

[31]  Bo Mattiasson,et al.  Affinity fractionation of lymphocytes using a monolithic cryogel. , 2003, Journal of immunological methods.

[32]  B. Hammer,et al.  Effect of harvesting protocol on performance of a hollow fiber bioreactor. , 1999, Biotechnology and bioengineering.

[33]  Wei-Shou Hu,et al.  Analysis of cellular metabolism of hybridoma cells at distinct physiological states. , 2003, Journal of bioscience and bioengineering.

[34]  C. Demangel,et al.  Role of metabolic waste products in the control of cell proliferation and antibody production by mouse hybridoma cells. , 1992, Hybridoma.

[35]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[36]  S L Morrison,et al.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Hauser,et al.  Cell lines with reduced UDP-N-acetylhexosamine pool in the presence of ammonium. , 1999, Biotechnology and bioengineering.

[38]  A. Pavlou,et al.  The therapeutic antibodies market to 2008. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  Q. Fang,et al.  Fed-batch culture optimization of a growth-associated hybridoma cell line in chemically defined protein-free media , 2007, Cytotechnology.

[40]  B Romein,et al.  Effects of glutamine supply on growth and metabolism of mammalian cells in chemostat culture. , 1997, Biotechnology and bioengineering.

[41]  Alejandro José Beccaria,et al.  Expression of recombinant cytoplasmic yeast pyruvate carboxylase for the improvement of the production of human erythropoietin by recombinant BHK-21 cells. , 2002, Journal of biotechnology.

[42]  A A Raubitschek,et al.  Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications. , 2001, Journal of immunological methods.

[43]  Annie Marc,et al.  Hybridoma cell behaviour in continuous culture under hyperosmotic stress , 2004, Cytotechnology.

[44]  Z. Darieva,et al.  Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis. , 2003, Biotechnology and bioengineering.

[45]  Martin Fussenegger,et al.  Impact of coexpression and coamplification of sICAM and antiapoptosis determinants bcl-2/bcl-x(L) on productivity, cell survival, and mitochondria number in CHO-DG44 grown in suspension and serum-free media. , 2002, Biotechnology and bioengineering.

[46]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[47]  Rob Winder.  Cell culture changes gear , 2005 .

[48]  Bo Mattiasson,et al.  Recovery of urokinase from integrated mammalian cell culture cryogel bioreactor and purification of the enzyme using p‐aminobenzamidine affinity chromatography , 2006, Journal of molecular recognition : JMR.

[49]  Bo Mattiasson,et al.  Synthesis, regulation and production of urokinase using mammalian cell culture: a comprehensive review. , 2006, Biotechnology advances.

[50]  Humphreys Dp,et al.  Therapeutic antibody production technologies: molecules, applications, expression and purification. , 2001 .

[51]  G. Lee,et al.  Osmoprotective Effect of Glycine Betaine on Thrombopoietin Production in Hyperosmotic Chinese Hamster Ovary Cell Culture: Clonal Variations , 2000, Biotechnology progress.

[52]  D S Kompala,et al.  Inclined Sedimentation for Selective Retention of Viable Hybridomas in a Continuous Suspension Bioreactor , 1990, Biotechnology progress.

[53]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[54]  Yuan-Kun Lee,et al.  Correlation between steady‐state cell concentration and cell death of hybridoma cultures in chemostat , 1995, Biotechnology and bioengineering.

[55]  J E Bailey,et al.  Effect of ammonium ion and extracellular pH on hybridoma cell metabolism and antibody production , 1990, Biotechnology and bioengineering.

[56]  Tomoaki Komatsu,et al.  Establishing apoptosis resistant cell lines for improving protein productivity of cell culture , 2004, Cytotechnology.

[57]  Gyun Min Lee,et al.  Response of recombinant Chinese hamster ovary cells to hyperosmotic pressure: effect of Bcl-2 overexpression. , 2002, Journal of biotechnology.

[58]  Shigeru Iida,et al.  Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.

[59]  Y. Chisti,et al.  Animal-cell damage in sparged bioreactors. , 2000, Trends in biotechnology.

[60]  Liangzhi Xie,et al.  Fed‐batch cultivation of animal cells using different medium design concepts and feeding strategies , 1994 .

[61]  David F. Ollis,et al.  Biochemical Engineering Fundamentals , 1976 .

[62]  C. Cooney,et al.  Model of oxygen transport limitations in hollow fiber bioreactors , 1991, Biotechnology and bioengineering.

[63]  D D Ryu,et al.  Cell cycle kinetics and monoclonal antibody productivity of hybridoma cells during perfusion culture , 1994, Biotechnology and bioengineering.

[64]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[65]  T Etcheverry,et al.  Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. , 2000, Biotechnology and bioengineering.

[66]  Johannes Tramper,et al.  On-line immunoanalysis of monoclonal antibodies during a continuous culture of hybridoma cells , 1997, Cytotechnology.

[67]  Christian Wandrey,et al.  The influence of dissolved oxygen tension on the metabolic activity of an immobilized hybridoma population , 2004, Cytotechnology.

[68]  Joachim Kuhn,et al.  High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase. , 2003, Journal of biotechnology.

[69]  G Stephanopoulos,et al.  Rapamycin reduces hybridoma cell death and enhances monoclonal antibody production. , 2001, Biotechnology and bioengineering.

[70]  David P Humphreys.  Production of antibodies and antibody fragments in Escherichia coli and a comparison of their functions, uses and modification. , 2003, Current opinion in drug discovery & development.

[71]  M Angela Taipa,et al.  Antibodies and Genetically Engineered Related Molecules: Production and Purification , 2004, Biotechnology progress.

[72]  D K Robinson,et al.  Effect of specific growth rates on productivity in continuous open and partial cell retention animal cell bioreactors. , 1992, Journal of biotechnology.

[73]  G. Adams,et al.  Monoclonal antibody therapy of cancer , 1999, Nature Biotechnology.

[74]  S. Mercille,et al.  Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. , 1999, Biotechnology and bioengineering.

[75]  Gyun Min Lee,et al.  Enhanced specific antibody productivity of hybridomas resulting from hyperosmotic stress is cell line-specific , 1995, Biotechnology Letters.

[76]  Anne W. Schmidt,et al.  Cultivation of HEK 293 cell line and production of a member of the superfamily of G-protein coupled receptors for drug discovery applications using a highly efficient novel bioreactor , 2004, Cytotechnology.

[77]  W C Davis,et al.  A novel continuous centrifugal bioreactor for high‐density cultivation of mammalian and microbial cells , 1991, Biotechnology and bioengineering.

[78]  E. Hood,et al.  Monoclonal antibody manufacturing in transgenic plants--myths and realities. , 2002, Current opinion in biotechnology.

[79]  W M Miller,et al.  Effects of dissolved oxygen concentration on hybridoma growth and metabolism in continuous culture , 1987, Journal of cellular physiology.

[80]  Z. Wen,et al.  A novel perfusion system for animal cell cultures by two step sequential sedimentation. , 2000, Journal of biotechnology.

[81]  M. Betenbaugh,et al.  Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants. , 2002, Biotechnology and bioengineering.

[82]  M Al-Rubeai,et al.  Influence of bcl-2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody. , 2000, Biotechnology and bioengineering.

[83]  Andrés Illanes,et al.  Specific nutrient supplementation of defined serum-free medium for the improvement of CHO cells growth and t-PA production , 2006 .

[84]  R. Bliem,et al.  Antibody production in packed bed reactors using serum-free and protein-free medium , 1990, Cytotechnology.

[85]  Wei-Shou Hu,et al.  Alteration of mammalian cell metabolism by dynamic nutrient feeding , 2004, Cytotechnology.

[86]  B. Buckland,et al.  Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.

[87]  D. Kong,et al.  High cell density and productivity culture of Chinese hamster ovary cells in a fluidized bed bioreactor , 2004, Cytotechnology.

[88]  Seong-Il Lee,et al.  Identification and Use of Zinc Finger Transcription Factors That Increase Production of Recombinant Proteins in Yeast and Mammalian Cells , 2008, Biotechnology progress.

[89]  B. Palsson,et al.  Effect of medium osmolarity on hybridoma growth, metabolism, and antibody production. , 1991, Biotechnology and bioengineering.

[90]  H. Fiebig,et al.  In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter. , 1995, Journal of immunological methods.

[91]  A J Sinskey,et al.  Large‐scale Production of Mammalian Cells and Their Products: Engineering Principles and Barriers to Scale‐up , 1983, Annals of the New York Academy of Sciences.

[92]  P Lane,et al.  Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis , 2003, Bioprocess and biosystems engineering.

[93]  H. J. Henzler,et al.  Oxygenation of cell cultures , 1993 .

[94]  Yuanxing Zhang,et al.  Optimization of monoclonal antibody production: combined effects of potassium acetate and perfusion in a stirred tank bioreactor , 1997, Cytotechnology.

[95]  F Gòdia,et al.  Improvement of CHO Cell Culture Medium Formulation: Simultaneous Substitution of Glucose and Glutamine , 2000, Biotechnology progress.

[96]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[97]  Ruian Xu,et al.  The bioreactor: a powerful tool for large-scale culture of animal cells. , 2005, Current pharmaceutical biotechnology.

[98]  Kris Thielemans,et al.  Generation of large numbers of dendritic cells in a closed system using Cell Factories. , 2002, Journal of immunological methods.

[99]  C A Heath,et al.  Partial and Total Cell Retention in a Filtration‐Based Homogeneous Perfusion Reactor , 1995, Biotechnology progress.

[100]  Yusuf Chisti,et al.  Characterization of shear rates in airlift bioreactors for animal cell culture , 1997 .

[101]  M. Moo-young,et al.  Statistical methods in media optimization for batch and fed-batch animal cell culture , 2007, Bioprocess and biosystems engineering.

[102]  Michael J. Betenbaugh,et al.  Part I. Bcl-2 and Bcl-xL limit apoptosis upon infection with alphavirus vectors. , 2000 .

[103]  M. Al‐Rubeai,et al.  Apoptosis and its control in cell culture systems , 2004, Cytotechnology.

[104]  J Zhang,et al.  Monoclonal antibody production with on-line harvesting and process monitoring. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[105]  F W Falkenberg,et al.  Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods. , 1998, Research in immunology.

[106]  P. F. Greenfield,et al.  Hybridoma growth limitations: The roles of energy metabolism and ammonia production , 2004, Cytotechnology.

[107]  Michael W. Glacken,et al.  Catabolic Control of Mammalian Cell Culture , 1988, Bio/Technology.

[108]  Brian Davis,et al.  Generation of a packaging cell line for prolonged large‐scale production of high‐titer HIV‐1‐based lentiviral vector , 2005, The journal of gene medicine.

[109]  M. Betenbaugh,et al.  Study of caspase inhibitors for limiting death in mammalian cell culture. , 2003, Biotechnology and bioengineering.

[110]  Michael J. Gramer,et al.  Comparison of cell growth in T-flasks, in micro hollow fiber bioreactors, and in an industrial scale hollow fiber bioreactor system , 2000, Cytotechnology.

[111]  K Low,et al.  Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations. , 1985, Developments in biological standardization.

[112]  H. Blanch,et al.  Cell retention–chemostat studies of hybridoma cells—analysis of hybridoma growth and metabolism in continuous suspension culture in serum‐free medium , 1993, Biotechnology and bioengineering.

[113]  Bo Mattiasson,et al.  Integrated bioprocess for the production and isolation of urokinase from animal cell culture using supermacroporous cryogel matrices , 2006, Biotechnology and bioengineering.

[114]  S. Masuda,et al.  A new biological strategy for high productivity of recombinant proteins in animal cells by the use of hypoxia-response enhancer. , 2000, Biotechnology and bioengineering.

[115]  T. Ellingsen,et al.  Hyperosmotic hbridoma cell cultures: Increased monoclonal antibody production with addition of glycine betaine , 1994, Biotechnology and bioengineering.

[116]  T. Ryll,et al.  Biochemistry of growth inhibition by ammonium ions in mammalian cells , 1994, Biotechnology and bioengineering.

[117]  Jochen Strube,et al.  Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodies , 2005 .

[118]  L. Trudel,et al.  Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production. , 1996, Journal of immunological methods.

[119]  Vijay P. Singh,et al.  Disposable bioreactor for cell culture using wave-induced agitation , 1999, Cytotechnology.

[120]  P. Blomberg,et al.  Clinical Grade Vector Production: Analysis of Yield, Stability, and Storage of GMP‐Produced Retroviral Vectors for Gene Therapy , 2004, Biotechnology progress.

[121]  A. Zeng,et al.  Determinants and rate laws of growth and death of hybridoma cells in continuous culture. , 1998, Biotechnology and bioengineering.

[122]  T. Ellingsen,et al.  Utilization of osmoprotective compounds by hybridoma cells exposed to hyperosmotic stress , 1994, Biotechnology and bioengineering.

[123]  Daniel I. C. Wang,et al.  High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. , 2000, Biotechnology and bioengineering.

[124]  D. Wendt,et al.  The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.

[125]  M. Gramer,et al.  Selection and isolation of cells for optimal growth in hollow fiber bioreactors. , 2000, Hybridoma.

[126]  Li Xie,et al.  Application of "oxygen uptake rate-amino acids" associated mode in controlled-fed perfusion culture. , 2006, Journal of biotechnology.

[127]  K. Ezra Kwok,et al.  Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates , 2003, Cytotechnology.

[128]  M. Gramer,et al.  Screening Tool for Hollow‐Fiber Bioreactor Process Development , 1998, Biotechnology progress.

[129]  Eiji Suzuki,et al.  Characterization and fed-batch culture of hybridoma overexpressing apoptosis suppressing gene bcl-2 , 1997, Cytotechnology.

[130]  J. Ljunggren,et al.  Glutamine limited fed-batch culture reduces the overflow metabolism of amino acids in myeloma cells , 2006, Cytotechnology.

[131]  A. Handa-Corrigan,et al.  Monoclonal antibody production in hollow-fiber bioreactors : process control and validation strategies for manufacturing industry , 1995 .

[132]  V M Yabannavar,et al.  Scaleup of spinfilter perfusion bioreactor for mammalian cell retention , 1994, Biotechnology and bioengineering.

[133]  A. Kamen,et al.  Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates. , 2000, Biotechnology and bioengineering.

[134]  R. Lemieux,et al.  Filtration‐based perfusion of hybridoma cultures in protein‐free medium: Reduction of membrane fouling by medium supplementation with DNase I , 1994, Biotechnology and bioengineering.

[135]  Gyun Min Lee,et al.  Influence of hyperosmolar basal media on hybridoma cell growth and antibody production , 1997 .

[136]  Julio A. Luna,et al.  Solving design equations for a hollow fiber bioreactor with arbitrary kinetics , 2001 .

[137]  M Al-Rubeai,et al.  In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. , 1998, Biotechnology and bioengineering.

[138]  B J Kobrin,et al.  Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility. , 2005, Cytotherapy.

[139]  M. Butler,et al.  The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. , 1997, Biotechnology and bioengineering.

[140]  George T. L. Land.  Grow or Die: The Principle of Transformation. , 1973 .

[141]  P. Cruz,et al.  Comparison of Different Bioreactor Systems for the Production of High Titer Retroviral Vectors , 2001, Biotechnology progress.

[142]  M Al-Rubeai,et al.  Bcl-2 over-expression reduces growth rate and prolongs G1 phase in continuous chemostat cultures of hybridoma cells. , 1999, Biotechnology and bioengineering.

[143]  Takeshi Kobayashi,et al.  Effect of dissolved oxygen concentration on monoclonal antibody production in hybridoma cell cultures , 1992 .

[144]  Marina Etcheverrigaray,et al.  Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells. , 2004, Journal of biotechnology.

[145]  Sadettin S. Ozturk,et al.  Engineering challenges in high density cell culture systems , 2004, Cytotechnology.

[146]  Bo Mattiasson,et al.  Monoclonal Antibody Production Using a New Supermacroporous Cryogel Bioreactor , 2007, Biotechnology progress.

[147]  S. Côté,et al.  Inducible expression of Bcl‐XL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures , 2002, Biotechnology and bioengineering.

[148]  D. Fassnacht,et al.  Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma , 1999, Cytotechnology.

[149]  D Matteuzzi,et al.  Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[150]  P. Greenfield,et al.  Calcium alginate immobilized hybridomas grown using a fluidized-bed perfusion system with a protein-free medium , 2004, Cytotechnology.

[151]  M. Al‐Rubeai,et al.  Cell death in bioreactors: A role for apoptosis , 1994, Biotechnology and bioengineering.

[152]  Suzanne S Farid,et al.  Process economics of industrial monoclonal antibody manufacture. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[153]  F Meuwly,et al.  Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells , 2003, Biotechnology and bioengineering.

[154]  H. Ueda,et al.  Overexpression of bcl‐2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production , 1995, Biotechnology and bioengineering.

[155]  W. Thilly,et al.  Growth of mammalian cells at high oxygen concentrations. , 1989, Journal of cell science.

[156]  Shang-Tian Yang,et al.  Effects of Three‐Dimensional Culturing in a Fibrous Matrix on Cell Cycle, Apoptosis, and MAb Production by Hybridoma Cells , 2008, Biotechnology progress.

[157]  S. Mercille,et al.  Induction of apoptosis in nutrient‐deprived cultures of hybridoma and myeloma cells , 1994, Biotechnology and bioengineering.

[158]  M. Betenbaugh,et al.  Life and death in mammalian cell culture: strategies for apoptosis inhibition. , 2004, Trends in biotechnology.

[159]  Paul F. Greenfield,et al.  Experience in scale-up of homogeneous perfusion culture for hybridomas , 1991 .

[160]  Tatiana Alvarez,et al.  CB.Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor , 2001, Cytotechnology.

[161]  T. Bibila,et al.  In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production , 1995, Biotechnology progress.

[162]  T. Gribnau,et al.  Monitoring of the production of monoclonal antibodies by hybridomas. Part I: Long-term cultivation in hollow fibre bioreactors using serum-free medium. , 1991, Journal of biotechnology.

[163]  K. H. Kim,et al.  Expression of carbamoyl phosphate synthetase I and ornithine transcarbamoylase genes in Chinese hamster ovary dhfr-cells decreases accumulation of ammonium ion in culture media. , 2000, Journal of biotechnology.

[164]  R. Vincentelli,et al.  Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free medium , 2004, Cytotechnology.

[165]  M. Tokashiki,et al.  Large-scale perfusion culture process for suspended mammalian cells that uses a centrifuge with multiple settling zones , 2004, Applied Microbiology and Biotechnology.

[166]  Ya-Jie Tang,et al.  A Perfusion Culture System Using a Stirred Ceramic Membrane Reactor for Hyperproduction of IgG2a Monoclonal Antibody by Hybridoma Cells , 2005, Biotechnology progress.

[167]  K Eyer,et al.  On‐line gas analysis in animal cell cultivation: II. Methods for oxygen uptake rate estimation and its application to controlled feeding of glutamine , 1995, Biotechnology and bioengineering.

[168]  Mohamed Al-Rubeai,et al.  Bioreactor systems for the production of biopharmaceuticals from animal cells , 2006, Biotechnology and applied biochemistry.

[169]  B O Palsson,et al.  Growth, Metabolic, and Antibody Production Kinetics of Hybridoma Cell Culture: 2. Effects of Serum Concentration, Dissolved Oxygen Concentration, and Medium pH in a Batch Reactor , 1991, Biotechnology progress.

[170]  Yan Wang,et al.  Improvement of Monoclonal Antibody Production in Hybridoma Cells by Dimethyl Sulfoxide , 2003, Biotechnology progress.

[171]  N S Kim,et al.  Overexpression of bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production. , 2000, Biotechnology and bioengineering.

[172]  W M Miller,et al.  Effects of Abrupt and Gradual Osmotic Stress on Antibody Production and Content in Hybridoma Cells That Differ in Production Kinetics , 1994, Biotechnology progress.

[173]  Bo Mattiasson,et al.  Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line. , 2006, Journal of chromatography. A.

[174]  J. Ljunggren,et al.  Metabolic Engineering of Animal Cells a , 1996, Annals of the New York Academy of Sciences.

[175]  R. Mutharasan,et al.  Cell cycle‐ and growth phase‐dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures , 1990, Biotechnology and bioengineering.

[176]  B O Palsson,et al.  Effects of Dissolved Oxygen on Hybridoma Cell Growth, Metabolism, and Antibody Production Kinetics in Continuous Culture , 1990, Biotechnology progress.

[177]  R. Lemieux,et al.  Long‐term perfusion culture of hybridoma: A “grow or die” cell cycle system , 1991, Biotechnology and bioengineering.

[178]  Victoria Boyd,et al.  Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice. , 2002, Journal of immunological methods.

[179]  D. I. Wang,et al.  Stoichiometric analysis of animal cell growth and its application in medium design , 1994, Biotechnology and bioengineering.

[180]  Joel R Charbonneau,et al.  Bcl-xL expression interferes with the effects of L-glutamine supplementation on hybridoma cultures. , 2003, Biotechnology and bioengineering.

[181]  F Franĕk,et al.  Nucleosomes occurring in protein‐free hybridoma cell culture Evidence for programmed cell death , 1991, FEBS letters.

[182]  M. Goosen,et al.  Performance of an external loop air-lift bioreactor for the production of monoclonal antibodies by immobilized hybridoma cells , 1989, Applied Microbiology and Biotechnology.

[183]  R. Pörtner,et al.  Experimental and theoretical considerations on oxygen supply for animal cell growth in fixed-bed reactors. , 1999, Journal of biotechnology.

[184]  A A Kamen,et al.  Use of the Centritech Lab Centrifuge for Perfusion Culture of Hybridoma Cells in Protein‐Free Medium , 1996, Biotechnology progress.

[185]  Mohamed Al-Rubeai,et al.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures , 2006, Cytotechnology.

[186]  D F Ollis,et al.  Enhanced Antibody Production at Slowed Growth Rates: Experimental Demonstration and a Simple Structured Model , 1990, Biotechnology progress.

[187]  U Marx.  Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies. , 1998, Research in immunology.

[188]  John C Joly,et al.  High‐level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple‐mutant (degP prc spr) host strain , 2004, Biotechnology and bioengineering.

[189]  T. Gribnau,et al.  Monitoring of the production of monoclonal antibodies by hybridomas. Part II: Characterization and purification of acid proteases present in cell culture supernatant. , 1991, Journal of biotechnology.

[190]  M Al-Rubeai,et al.  Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. , 2000, Journal of biotechnology.

[191]  F. Gòdia,et al.  Modification of glucose and glutamine metabolism in hybridoma cells through metabolic engineering , 1999, Cytotechnology.

[192]  E. H. Dunlop,et al.  Studies of the shear protective effects of Pluronic F-68 on wild carrot cell cultures , 2002 .

[193]  M. Moo-Young,et al.  Effect of oxygen on antibody productivity in hybridoma culture , 1987, Biotechnology Letters.

[194]  G. Fleuren,et al.  Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor. , 1993, Journal of immunological methods.

[195]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.

[196]  Michel Chartrain,et al.  Evaluation of Disposable Bioreactors Rapid Production of Recombinant Proteins By Several Animal Cell Lines , 2005 .

[197]  A. Kadouri,et al.  Modified CelliGen-packed bed bioreactors for hybridoma cell cultures , 1992, Cytotechnology.

[198]  J. M. Chong,et al.  Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. , 1999, Journal of immunological methods.

[199]  A. Pavlou,et al.  Monoclonal antibodies market , 2004, Nature Reviews Drug Discovery.

[200]  Hiroyuki Takamatsu,et al.  Perfusion culture apparatus for suspended mammalian cells , 2004, Cytotechnology.

[201]  Janice M Reichert,et al.  Monoclonal antibody successes in the clinic , 2005, Nature Biotechnology.

[202]  M Al-Rubeai,et al.  Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. , 1997, Biotechnology and bioengineering.

[203]  James E. Bailey,et al.  Influence of dissolved oxygen concentration on growth, mitochondrial function and antibody production of hybridoma cells in batch culture , 1990 .

[204]  Patrick Vermette,et al.  Bioreactors for tissue mass culture: design, characterization, and recent advances. , 2005, Biomaterials.

[205]  Francesc Gòdia,et al.  The protection of hybridoma cells from apoptosis by caspase inhibition allows culture recovery when exposed to non-inducing conditions. , 2002, Journal of biotechnology.

[206]  Yusuf Chisti,et al.  Animal cell culture in stirred bioreactors: Observations on scale-up , 1993 .

[207]  Mei-Jywan Syu,et al.  Anti-Hepatitis B surface Antigen monoclonal antibody IgM production in suspension and immobilized cell bioreactors , 2005, Biotechnology Letters.

[208]  A. N. Emery,et al.  Oxygenation of intensive cell-culture system , 1995, Applied Microbiology and Biotechnology.

[209]  J. Ljunggren,et al.  Physiology of cultured animal cells. , 1997, Journal of biotechnology.

[210]  J E Dowd,et al.  Predictive control of hollow-fiber bioreactors for the production of monoclonal antibodies. , 1999, Biotechnology and bioengineering.

[211]  Johannes Tramper,et al.  Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution. , 2004, Biotechnology and bioengineering.

[212]  D. Reilly,et al.  Production technologies for monoclonal antibodies and their fragments. , 2004, Current opinion in biotechnology.

[213]  George Georgiou,et al.  Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli , 2007, Nature Biotechnology.

[214]  Mark R. Riley,et al.  Glutamine replenishment and ammonia removal in hybridoma cell cultures via immobilized glutamine synthetase , 2001 .

[215]  C A Heath,et al.  High-density hybridoma perfusion culture , 1997, Applied biochemistry and biotechnology.

[216]  W. Teo,et al.  Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate , 1993, Biotechnology and bioengineering.

[217]  G. Boulianne,et al.  Production of functional chimaeric mouse/human antibody , 1984, Nature.

[218]  B O Palsson,et al.  Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production , 1992, Biotechnology and bioengineering.

[219]  M. Al‐Rubeai,et al.  Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. , 1990, Journal of biotechnology.

[220]  P. Nabet,et al.  Methods for reducing the ammonia in hybridoma cell cultures. , 1995, Journal of biotechnology.

[221]  Lena Häggström,et al.  Detoxification of ammonium in bioreactor cultivations , 1994 .

[222]  A. Nienow,et al.  Further studies of the culture of mouse hybridomas in an agitated bioreactor with and without continuous sparging. , 1992, Journal of biotechnology.

[223]  Axel Munack,et al.  Adaptive, Model‐Based Control by the Open‐Loop‐Feedback‐Optimal (OLFO) Controller for the Effective Fed‐Batch Cultivation of Hybridoma Cells , 2002, Biotechnology progress.

[224]  Christian Wandrey,et al.  INTEGRATED DETOXIFICATION: REDUCTION OF AMMONIUM CONCENTRATION BY DIALYSIS WITH CATION EXCHANGE MEMBRANES , 1992 .

[225]  C. Goochee,et al.  Structural Features of Nonionic Polyglycol Polymer Molecules Responsible for the Protective Effect in Sparged Animal Cell Bioreactors , 1990, Biotechnology progress.

[226]  S. R. Nathan,et al.  A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma. , 2000, Biotechnology and bioengineering.

[227]  Pao C. Chau,et al.  Modeling of Axial‐Flow Hollow Fiber Cell Culture Bioreactors , 1996 .